Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
China Pharmacy ; (12): 1153-1155, 2017.
Article in Chinese | WPRIM | ID: wpr-514993

ABSTRACT

OBJECTIVE:To evaluate the level of quality standard for Chinese patent medicine types included in National Essen-tial Medicine List(2012 edition),and to provide reference for the selection of Chinese patent medicine types in the next edition of National Essential Medicine List. METHODS:By retrieving the relevant national standards of Chinese patent medicine,collecting the key information about their quality standard,database establishment and data analysis were conducted for quality standard of Chinese patent medicine. RESULTS&CONCLUSIONS:There were 371 preparations included in the 2012 edition of National Essen-tial Medicine List. Among them,267 preparations were included in part I of Chinese Pharmacopoeia(2015 edition);71.97% car-ried out pharmacopoeia quality standard. The quality standard system was perfect;the quality control items and the detection meth-ods were abundant;and the safety control technology was strengthened. The quality standard of 104 TCM preparations carried out non-pharmacopoeia standards,accounting for 28.03% of the total;among which,the quality standard for 18 TCM preparations were from Medicine Standard of Ministry of Public Health of Peoples Republic of China·Preparation Containing Traditional Chi-nese Medicine;the quality standard for 6 TCM preparations came from National Standards Compilation for Chinese Patent Medi-cines;both were relatively early quality standards. There are some problems,such as absence of identification and content determi-nation,few ingredient for identification,few index and components for measurement. The quality standards of preparations are to be improved.

2.
Chinese Journal of Biochemical Pharmaceutics ; (6): 122-124,127, 2015.
Article in Chinese | WPRIM | ID: wpr-602366

ABSTRACT

Objective To investigate the effect of granulesten on hs-CRP and lipid in patients with stroke.Methods 76 patients with acute ischemic stroke were selected and randomly divided into two groups.38 cases in the control group were treated by conventional therapy, 38 cases in the experiment group were treated on the basis of the control group with granulesten.hs-CRP, IL-6, Hcy, and lipid fat were detected and the clinic effect were compared after the treatment.ResuIt Compared with control group, hs-CRP, IL-6, and Hcy of the experiment group were lower(P<0.05), TC, TG and LDL-C were lower, HDL-C was higher ( P<0.05 ) , the clinic effect was higher ( P<0.05 ) , the rate of side effect was higher ( P<0.05 ) . ConcIusion Granulester can significantly reduce serum hs-CRP, IL-6 and Hcy levels, improve blood lipid metabolism, improve the clinical efficacy, and adverse reactions are mild, it has important significance for patients with acute ischemic stroke.

3.
Chinese Journal of Postgraduates of Medicine ; (36): 6-8, 2011.
Article in Chinese | WPRIM | ID: wpr-416025

ABSTRACT

Objective To investigate the efficacy of methotrexate combined with mifepristone prophylaxis for persistent ectopic pregnancy (PEP) after laparoscopic conservative surgery. Methods One hundred and twenty cases of tubal pregnancy were randomly divided into two groups by admission number, the study group (60 cases) were treated by mifepristone before laparoscopic conservative surgery and methotrexate combined with mifepristone after laparoscopic conservative surgery, but the control group (60 cases) were treated by laparoscopic conservative surgery, the bleeding was observated in the surgery,concentration of β-human chorionic gonadotrop ( β-hCG) was detected before operation and 1,3,7,12 d after operation. Results There were significant differences in β-hCG after operation 3,7,12 d between two groups(P<0.05). The bleeding was (21.8 ?.2) ml in study group,and (38.1 ?3.1) ml in control group, there was significant difference between two groups (P<0.05). In study group, the incidence of PEP was 0, and 3.33%(2/60) in control group. Conclusion Preoperative mifepristone and postoperative mifepristone combined with methotrexate in preventing PEP after laparoscopic conservative surgery is efficacy, and it can be chosen in clinic.

SELECTION OF CITATIONS
SEARCH DETAIL